Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
320 Leser
Artikel bewerten:
(1)

ClaroNav Inc.: ClaroNav Dental Announces CE Mark: EU Marketing Authorization for MicronMapper

A Groundbreaking Advancement in Photogrammetry for Dental Procedures

TORONTO, Oct. 10, 2024 /PRNewswire/ -- ClaroNav Dental, a digital dental solution company, is proud to announce that its revolutionary MicronMapper photogrammetry system is now officially CE-marked for sale in Europe. This marks a significant milestone in the company's commitment to providing cutting-edge tools that enhance accuracy and precision in dental procedures across the globe.

MicronMapper

MicronMapper is ClaroNav Dental's next-generation photogrammetry system designed to streamline and improve the dental implant workflow. With a lightweight, easy-to-use design, and advanced 3D photogrammetry capabilities, MicronMapper enables dental professionals to capture highly detailed and precise implant positions resulting in more predictable outcomes and a high level of patient satisfaction. It significantly reduces the need for traditional, time-consuming methods, such as verification jigs or impressions, making it ideal for full-arch restorations and other complex procedures.

Key Features of MicronMapper:

  • Ultra-Lightweight Design: Weighing just over 1 lb., it offers maximum mobility and ease of use during scanning.
  • Dual-Purpose Functionality: Utilizes the same scan body for both soft tissue and photogrammetry scans, simplifying the workflow.
  • Exceptional Accuracy: Photogrammetry enables clinicians to achieve unparalleled precision, ensuring more predictable passive fit outcomes.

"We are thrilled to announce the CE-marking of MicronMapper," said Doron Dekel, Co-CEO of ClaroNav. "This device represents a significant leap forward in digital dentistry, allowing clinicians to achieve higher accuracy in less time, ultimately improving both patient care and clinical outcomes. With MicronMapper, we are not just meeting the needs of today's dental professionals, but also shaping the future of implant dentistry."

"MicronMapper is more than just a technological advancement; it's a game-changer for dental practices from both an operational and financial perspective," said Tom Tilmans, EMEA Sales Director at ClaroNav Dental. "By streamlining complex workflows and reducing chair time, clinics can see immediate improvements in efficiency and cost savings. At the same time, the enhanced precision of MicronMapper directly translates to better clinical outcomes and a superior patient experience, making it an essential tool for any forward-thinking dental practice."

MicronMapper's EU marketing authorization opens doors for dental practices across the European continent to integrate this innovative technology, transforming workflows and enhancing the quality of care provided to patients. The system is already gaining momentum globally for its ability to make complex procedures simpler, faster, and more precise.

With this approval, ClaroNav Dental continues to expand its footprint in international markets, furthering its mission to provide accessible, state-of-the-art tools to dental professionals and their patients worldwide.

About ClaroNav Dental:

ClaroNav Dental is a pioneering company specializing in dynamic navigation and image capture technology for the dental industry. Their innovative products, including Navident EVO and MicronMapper, are designed to transform dental procedures by enhancing precision, efficiency, and patient outcomes. ClaroNav Dental is dedicated to advancing dental technology to meet the evolving needs of clinicians worldwide.

To learn more about Navident EVO and all the ClaroNav Dental products, please visit our new website at www.claronavdental.com.

1 (844) 628-4336, www.claronavdental.com, info@claronavdental.com

ClaroNav Dental Logo

Photo - https://mma.prnewswire.com/media/2526977/ClaroNav_Inc__ClaroNav_Dental_Announces_CE_Mark__EU_Marketing_Au.jpg

Logo - https://mma.prnewswire.com/media/2526978/ClaroNav_Inc__ClaroNav_Dental_Announces_CE_Mark__EU_Marketing_Au.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/claronav-dental-announces-ce-mark-eu-marketing-authorization-for-micronmapper-302271992.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.